Identification of a Distinct Platelet Phenotype in the Elderly: ADP Hypersensitivity Coexists With Platelet PAR (Protease-Activated Receptor)-1 and PAR-4–Mediated Thrombin Resistance
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of a Distinct Platelet Phenotype in the Elderly: ADP Hypersensitivity Coexists With Platelet PAR (Protease-Activated Receptor)-1 and PAR-4–Mediated Thrombin Resistance
Authors
Keywords
-
Journal
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Volume 42, Issue 8, Pages 960-972
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2022-06-16
DOI
10.1161/atvbaha.120.316772
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating platelet‐derived extracellular vesicles are decreased after remote ischemic preconditioning in patients with coronary disease: A randomized controlled trial
- (2021) Caroline J. Reddel et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Rapid Release of Interleukin-1β from Human Platelets Is Independent of NLRP3 and Caspase
- (2021) Gabrielle J. Pennings et al. THROMBOSIS AND HAEMOSTASIS
- Determination of PAR4 numbers on the surface of human platelets: no effect of the single nucleotide polymorphism rs773902
- (2020) Simeng Li et al. PLATELETS
- TNF-alpha driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging
- (2019) Pavel Davizon-Castillo et al. BLOOD
- High on-treatment platelet reactivity and outcome in elderly with non ST-segment elevation acute coronary syndrome - Insight from the GEPRESS study
- (2018) Roberta De Rosa et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Prognostic Impact of Soluble P-Selectin on Long-Term Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
- (2018) Maximilian Tscharre et al. THROMBOSIS AND HAEMOSTASIS
- Granzyme A in Human Platelets Regulates the Synthesis of Proinflammatory Cytokines by Monocytes in Aging
- (2017) Robert A. Campbell et al. JOURNAL OF IMMUNOLOGY
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
- (2017) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protease-Activated Receptor PAR-4: An Inducible Switch between Thrombosis and Vascular Inflammation?
- (2017) Bernhard Rauch et al. THROMBOSIS AND HAEMOSTASIS
- Platelets as a novel source of Gremlin-1: Implications for thromboinflammation
- (2017) Madhumita Chatterjee et al. THROMBOSIS AND HAEMOSTASIS
- Decreased platelet reactivity in patients with cancer is associated with high risk of venous thromboembolism and poor prognosis
- (2017) Julia Riedl et al. THROMBOSIS AND HAEMOSTASIS
- Protease-activated receptors in hemostasis
- (2016) M. T. Nieman BLOOD
- Development and characterization of monoclonal antibodies against Protease Activated Receptor 4 (PAR4)
- (2015) Michele M. Mumaw et al. THROMBOSIS RESEARCH
- Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases
- (2014) C. Franceschi et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Protease-activated Receptor 1 (PAR1) and PAR4 Heterodimers Are Required for PAR1-enhanced Cleavage of PAR4 by α-Thrombin
- (2013) Amal Arachiche et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ticagrelor Versus Clopidogrel in Elderly Patients With Acute Coronary Syndromes
- (2012) Steen Husted et al.
- High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET study
- (2011) J. Silvain et al. EUROPEAN HEART JOURNAL
- Platelet Matrix Metalloprotease-1 Mediates Thrombogenesis by Activating PAR1 at a Cryptic Ligand Site
- (2009) Vishal Trivedi et al. CELL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started